Literature DB >> 6833171

Leishmania mexicana: drug sensitivities of promastigotes and transforming amastigotes.

G H Coombs, D T Hart, J Capaldo.   

Abstract

A comparison has been made of the effects of a range of antiprotozoal drugs and other metabolic inhibitors upon growing promastigotes and transforming amastigotes of Leishmania mexicana mexicana. Amastigotes transforming to promastigotes in vitro were highly susceptible to 2-mercaptoacetate, 4-pentenoate, alpha-difluoromethylornithine, ethidium bromide, acridine orange, pentamidine isethionate, allopurinol, amphotericin B, menoctone and pentostam. Promastigotes were in most cases less sensitive to these inhibitors. The results reiterate that the biochemical differences between the two developmental forms are reflected in their sensitivities to inhibitors. The transformation in vitro of Leishmania amastigotes to promastigotes may be a useful model for use as a primary screen for antileishmanial agents.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6833171     DOI: 10.1093/jac/11.2.151

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

Review 1.  Imaging flow cytometry analysis of intracellular pathogens.

Authors:  Viraga Haridas; Shahin Ranjbar; Ivan A Vorobjev; Anne E Goldfeld; Natasha S Barteneva
Journal:  Methods       Date:  2016-09-15       Impact factor: 3.608

2.  DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening.

Authors:  D Sereno; G Roy; J L Lemesre; B Papadopoulou; M Ouellette
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

3.  Polyamine content and drug sensitivities of different clonal lines of Leishmania infantum promastigotes.

Authors:  L Carrera; R Balaña-Fouce; J M Alunda
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

4.  First Total Synthesis of ω-Phenyl Δ6 Fatty Acids and their Leishmanicidal and Anticancer Properties.

Authors:  Nestor M Carballeira; Christian Morales-Guzman; Ester Alvarez-Benedicto; Zally Torres-Martinez; Yamixa Delgado; Kai H Griebenow; Arthur D Tinoco; Rosa M Reguera; Yolanda Perez-Pertejo; Ruben Carbajo-Andres; Rafael Balana-Fouce
Journal:  Curr Top Med Chem       Date:  2018       Impact factor: 3.295

5.  In vitro antileishmanial drug susceptibility of clinical isolates from patients with Indian visceral leishmaniasis--status of newly introduced drugs.

Authors:  Vijay Kumar Prajapati; Sanjana Mehrotra; Shalini Gautam; Madhukar Rai; Shyam Sundar
Journal:  Am J Trop Med Hyg       Date:  2012-08-27       Impact factor: 2.345

6.  The mRNA-bound Proteome of Leishmania mexicana: Novel Genetic Insight into an Ancient Parasite.

Authors:  Luis M de Pablos; Tiago R Ferreira; Adam A Dowle; Sarah Forrester; Ewan Parry; Katherine Newling; Pegine B Walrad
Journal:  Mol Cell Proteomics       Date:  2019-04-04       Impact factor: 5.911

7.  High content analysis of primary macrophages hosting proliferating Leishmania amastigotes: application to anti-leishmanial drug discovery.

Authors:  Nathalie Aulner; Anne Danckaert; Eline Rouault-Hardoin; Julie Desrivot; Olivier Helynck; Pierre-Henri Commere; Hélène Munier-Lehmann; Gerald F Späth; Spencer L Shorte; Geneviève Milon; Eric Prina
Journal:  PLoS Negl Trop Dis       Date:  2013-04-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.